PharmD Capital Trading with PharmD_KS

PharmD Capital Trading with PharmD_KS

Market Analysis and Trades for 11/26, 11/28

PharmD_KS's avatar
PharmD_KS
Nov 25, 2025
∙ Paid

If you are looking to join the Discord (now separate from the newsletter) please see here: JOIN THE DISCORD Please email help@pharmdcapital.com if there are any technical issues. Plans/levels will be posted in the Discord so the Discord option includes Substack content but a new Substack subscription does not include Discord access.

Be sure you have read the Starter Kit, including the free section even if you’re a paid subscriber. Trading Doggy Style Starter Kit

The weekly post for SPY 0.00%↑ and QQQ 0.00%↑ should be reviewed prior to this. It can be found here Market Analysis for the Week of 11/23

Today was a great example of the importance of internally segregating timeframes. From the weekly plan, we were looking for a move to Thursday’s open and high above Friday’s high but knew that it was unlikely to be as clean as traditional price action might suggest:

It is easy to look at the below chart in hindsight and think it looked easy, but this morning’s liquidation break (for which we were prepared) looked anything but bullish as it was unfolding.

The profile was susceptible to this liquidation break as yesterday (inclusive of overnight) had thin structure relative to the volume put in at high of day at an area of known resistance:

The short setup was triggered with the look above and fail of 6729.5-6731.75 on ES and 24969-24977 on NQ and accelerated with the loss of 6709-6715 on ES and 24869-24882, 24817-24832 on NQ

The short was amazing, but bulls defended where they had to. Once the IB high on NQ (in the 869-882 weekly range) and ES 6741 was lifted it was lights out for sellers.

Today once again had an upward spike into the close at an area of major resistance after taking Friday’s high. The binary nature of this spot is rather apparent:

Paid Content Below or in the Discord

JOIN THE DISCORD

PharmD Capital Trading with PharmD_KS is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

Keep reading with a 7-day free trial

Subscribe to PharmD Capital Trading with PharmD_KS to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 PharmD_KS
Market data by Intrinio
Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture